NeuBase Therapeutics (NBSE) Q1 2023 Earnings

May 11Confirmed
Aug 2022
Dec 2022
Q4 2022
Q1 2023
-0.3
-0.24
-0.17
-0.11

Details

Expected EPS
-0.11
Actual EPS
-0.12
Surprise EPS
-0.01
Surprise Percent
-9.09%

Description

⁨NeuBase Therapeutics⁩ (⁦NBSE⁩) has reported earnings of ⁦-0.12⁩ per share for ⁦Q1 2023⁩.

0 Comments

Share your thoughts